NextGen Omics Event in London: A Confluence of Technology and Insights
11/9/23
11/10/23
Offline
London, United Kingdom
Share
From November 9th to 10th, London hosted the NextGen Omics conference, a pivotal event in genomics and omics technologies. The MGI Tech team expressed gratitude for the exceptional exchange of insights, collaborations, and networking opportunities at our booth. The success of the conference was attributed to tireless organizers, seamlessly blending cutting-edge research and interactive discussions.
MGI Tech, a key player in genomics, showcased innovation and collaboration at the booth, with an enthusiastic response from attendees. Our newly launched local website, mgi-tech.eu, invites exploration into our advancements and cutting-edge solutions in genomics and omics technologies.
Reflecting on the days at NextGen Omics, we are grateful for the opportunity to connect with passionate individuals, shaping the future of genomics. Thanks to organizers, participants, and contributors, the event set the stage for transformative advancements in this rapidly evolving field. The journey to unlock the mysteries of genomics and omics technologies continues, and we are excited to be at the forefront of this transformative adventure.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
GENOMICS
NGS
NEXTGEN OMICS
EXCELLONDON
NETWORKING
Share this article :
Share
More Events
Sep 12, 2026
MGI Tech at ECP 2026: Advancing Pathology with Genomics and Proteomics
Discover MGI’s latest genomic and proteomic solutions at ECP 2026, designed to empower pathologists and researchers with new approaches to tissue and disease analysis and accelerate the transition toward more comprehensive, data-driven pathology.
Sep 28, 2026
From data to discovery: MGI showcases spatial biology use cases at ESSB 2026
Discover how spatial and single-cell technologies can turn complex tissue biology into actionable biological insight. Meet MGI at ESSB 2026 and explore our latest Stereo-seq use cases and scientific presentations.
Jun 29, 2026
Exploring the Future of Spatial Transcriptomics at STOC 2026
oin us in Milan at the STOC General Meeting together with the STOmics team. Discover the latest innovations in spatial transcriptomics, explore emerging applications in spatial biology, and connect with our experts to discuss how cutting-edge technologies can advance your research.